col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


82 Results       Page 1

 [1] 
Elsevier: Pathology
  original article Date Title Authors   All Authors
1 [GO] 2024―May―06 Increase in invasive Haemophilus influenzae serotype A infections during the COVID-19 pandemic in New South Wales, Australia Winkie Fong, Elena Martinez, Verlaine Timms, Andrew Ginn, Trang Nguyen, Hossinur Rahman, Vitali Sintchenko
2 [GO] 2024―Apr―24 Continued improvement in the development of the SARS-CoV-2 whole genome sequencing proficiency testing program Katherine A. Lau, Charles S.P. Foster, Torsten Theis, Jenny Draper, Mitchell J. Sullivan, Susan Ballard, William D. Rawlinson
3 [GO] 2024―Apr―06 Trends in SARS-CoV-2 cycle threshold (Ct) values from nucleic acid testing predict the trajectory of COVID-19 waves Vishal Ahuja, Thomas Bowe, Gayle Warnock, Catherine Pitman, Dominic E. Dwyer
4 [GO] 2024―Mar―26 Dermatopathic lymphadenopathy after COVID-19 vaccination Jie-Yang Jhuang, Yen-Chieh Chen, Yung-Fang Chia, Shih-Sung Chuang
5 [GO] 2024―Jan―27 Irregular and out-of-season re-emergence of respiratory pathogens after lifting of COVID-19 pandemic response measures, Singapore Matthias Maiwald, Han Yang Soong, Wei Yee Wan, Liat Hui Loo
6 [GO] 2023―Oct―18 Fatal heart arrhythmia associated with enterovirus cardiac infection and SARS-CoV-2-induced cytokine storm Domitille Callon, Yohan N’Guyen, Paul Fornes, Laurent Andreoletti
7 [GO] 2023―Oct―12 Experience with COVID-19: swab technique shows no association with willingness to retest Haley Ruiz, Victoria Westley-Wise, Darren J. Mayne, Caitlin Keighley, Peter Newton, Spiros Miyakis, Holly Seale
8 [GO] 2023―Sep―01 SARS-CoV-2 infection of the placenta is associated with extensive fibrin deposition which may cause adverse pregnancy outcomes Stuart T. Hamilton, Christine Loo, Martin A. Weber, Roshini John, Antonia Shand, William D. Rawlinson
9 [GO] 2023―Aug―26 Vertical transmission of SARS-CoV-2 from mother to fetus Cosmin I. Mohor, George C. Oprinca, Alexandra Oprinca-Muja, Sorin R. Fleacă, Adrian Boicean, Ioana Boeraș, et al. (+2)
10 [GO] 2023―Aug―19 A case of COVID-19 mRNA vaccine-related erythema nodosum and interstitial granulomatous drug reaction Mingjuan Tan, Jamie J.M. Phua, Kuttiparambil Unnikrishnan, Kong Bing Tan, Chris Li Xian Tan
11 [GO] 2023―Jul―28 Cytomegalovirus and Aspergillus co-infection in an immunocompetent patient with severe COVID-19 Adina Dessauer, Daniel Hussey, Sadid F. Khan, Catriona A. McLean, Bradley J. Gardiner
12 [GO] 2023―Apr―09 Performance evaluation of Roche and Abbott Panbio multiplex SARS-CoV-2 and influenza A/B rapid antigen tests Mitchell Batty, Charlene Mackenzie, Joshua Deerain, Thomas Tran, Yano Yoga, Julian Druce, et al. (+2)
13 [GO] 2023―Jan―27 Maternal COVID-19 infection and subacute placental histopathology Bruce Tsz Chun Chau, Jin Sung Byun, Leonardo Santos, Patricia Symons
14 [GO] 2023―Jan―27 Evaluating vitamin D levels during the NSW 2020 COVID-19 lockdown S. Clayton, B. Graham, K. Fildes, S. Min, C. Keighley
15 [GO] 2022―Aug―06 Analysis of SARS-CoV-2 real-time PCR test CT values across a population may afford useful information to assist public health efforts and add refinement to epidemiological models Robert Stevens, Ryan Pratama, Zin Naing, Anna Condylios
16 [GO] 2022―Aug―06 Severe autoimmune haemolytic anaemia following SARS-CoV-2 vaccination in patients with treatment naïve B-cell neoplasms: a case series Joshua Haron Abasszade, Paul Bao Duy La, Emily Shelmerdine, Anastasios Nalpantidis, Natasha Curtin, George Grigoriadis, Pasquale Luke Fedele
17 [GO] 2022―Jul―02 Cadaveric donor specimens and serological testing for SARS-CoV-2 Malinna Yeang, Vidiya Ramachandran, Zin Naing, Chee Choy Kok, William D. Rawlinson
18 [GO] 2022―Jun―29 Factors associated with weak positive SARS-CoV-2 diagnosis by reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) Priyank Rawat, Jennifer M. Zerbato, Ajantha Rhodes, Chris Chiu, Thomas Tran, Thomas A. Rasmussen, et al. (+3)
19 [GO] 2022―Jun―29 Proficiency testing for SARS-CoV-2 whole genome sequencing Katherine A. Lau, Kristy Horan, Anders Gonçalves da Silva, Alexa Kaufer, Torsten Theis, Susan A. Ballard, William D. Rawlinson
20 [GO] 2022―Jun―09 Neuropathological findings in fatal COVID-19 and their associated neurological clinical manifestations Ignacio Ruz-Caracuel, Héctor Pian-Arias, Íñigo Corral, Irene Carretero-Barrio, Diego Bueno-Sacristán, Belén Pérez-Mies, et al. (+10)
21 [GO] 2022―May―28 Pathology utilisation during COVID-19 outbreaks beyond viral testing: routine coagulation and D-dimer testing Emmanuel J. Favaloro, Michelle Lay, Soma Mohammed, Ronny Vong, Leonardo Pasalic
22 [GO] 2022―May―23 Local genomic sequencing enhances COVID-19 surveillance in the Northern Territory of Australia Ella M. Meumann, Dimitrios Menouhos, Stefanos Christofis, Kwaku M. Kondambu-Saaka, Jaimee Harbidge, Farshid Dakh, et al. (+2)
23 [GO] 2022―Apr―21 Evaluation of the influenza and respiratory syncytial virus (RSV) targets in the AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay: sample pooling increases testing throughput Thuy Phan, Ngoc Yen Kim Tran, Thomas Gottlieb, Steven Siarakas, Genevieve McKew
24 [GO] 2022―Apr―16 SARS-CoV-2 N-gene mutation leading to Xpert Xpress SARS-CoV-2 assay instability Charles S.P. Foster, Mathew Madden, Raymond Chan, David Agapiou, Rowena A. Bull, William D. Rawlinson, Sebastiaan J. Van Hal
25 [GO] 2022―Apr―16 SARS-CoV-2 IgM testing for travellers: a private pathology perspective from New South Wales and the Australian Capital Territory, Australia Michael C. Wehrhahn, Gretschen Millan, James P. Newcombe, Matthew Long, Caitlin Keighley, Paul Whiting, Ian Chambers
26 [GO] 2022―Apr―16 Proficiency testing for SARS-CoV-2 in assuring the quality and overall performance in viral RNA detection in clinical and public health laboratories Katherine A. Lau, Alexa Kaufer, Joanna Gray, Torsten Theis, William D. Rawlinson
27 [GO] 2022―Feb―10 Clinical associations of SARS-CoV-2 viral load using the first WHO International Standard for SARS-CoV-2 RNA Peter Boan, Andrew Jardine, Todd M. Pryce
28 [GO] 2022―Feb―03 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody kinetics after BNT162B2 vaccination Ravin Hettiarachchi, Kartik Naidu, Suzanne Payne, Juliette Holland
29 [GO] 2022―Feb―03 False positive results seen at high CT values with the Xpert Xpress SARS-CoV-2 test Shireen Y.L. Tan, Sui Sin Goh, Kenneth X.L. Chan, James H.C. Sim, Karrie K.K. Ko
30 [GO] 2022―Feb―03 A case of prolonged SARS-CoV-2 viral shedding for 150 days Andrew Fox-Lewis, Shivani Fox-Lewis, Sandra Hotu, Sally Roberts, Gary McAuliffe, Mary De Almeida
31 [GO] 2022―Feb―03 Rapid antigen tests for positive Covid-19 confirmation in the laboratory setting Mikaela Dewar, Anica Pjevalica, Nicholas Clay, Brock Reitzer-Parks, Caitlin L. Keighley
32 [GO] 2022―Feb―03 Management of deaths in temporal relationship to COVID-19 immunisation in NSW Isabel Brouwer, Dianna Inmon, Angela Duncan
33 [GO] 2022―Feb―03 An update on Covid-19 serology Paul M. Kinsella, Theo Karapanagiotidis, Suellen Nicholson, Deborah A. Williamson
34 [GO] 2022―Feb―03 Investigation of deaths following COVID-19 vaccination in Western Australia Kirralee Patton, Leana Downs, Clive Cooke, Jodi White, Victoria Kueppers
35 [GO] 2022―Feb―03 Discordant SARS-CoV-2 RNA results obtained using the Roche cobas liat SARS-CoV-2 Gayle Warnock, Peter Newton
36 [GO] 2022―Feb―03 Severe terminal ileitis following SARS-CoV-2 infection: A histopathological case report Brett Fivelman, Angela Harris
37 [GO] 2022―Feb―03 Airborne transmission of SARS-CoV-2 lineage B.1.617.2 (Delta variant) within a tightly monitored isolation facility Andrew Fox-Lewis, Felicity Williamson, Jay Harrower, Xiaoyun Ren, Gerard J.B. Sonder, Andrea McNeill, et al. (+2)
38 [GO] 2022―Feb―03 De novo design of CRISPR-Cas13b enables efficient silencing of SARS-CoV-2 variants and tumour pathogenic RNAs with near single-base precision Wenxin Hu, Wei Zhao, Amit Kumar, Gurjeet Jagjeet Singh, Shijiao Qi, Josh Casan, et al. (+12)
39 [GO] 2022―Feb―03 SARS-CoV-2 viral load dynamics and real-time RT-PCR cycle threshold interpretation in symptomatic non-hospitalised individuals in New Zealand: A multicentre cross-sectional observational study Andrew Fox-Lewis, Shivani Fox-Lewis, Jenna Beaumont, Dragana Drinković, Jay Harrower, Kevin Howe, et al. (+10)
40 [GO] 2022―Feb―03 An unusual case of heparin-induced thrombocytopenia in a patient infected with SARS-CoV-2 virus Jian Li
41 [GO] 2022―Feb―03 Verification and implementation of a rapid antigen test for SARS-CoV2 detection in clinical settings in Sydney local health district (SLHD) Susy Mathew, John Saunders, Jacquelyn Petty, Rebecca Davis
42 [GO] 2022―Feb―02 Validation of specimen pooling using the Cepheid Xpert Xpress SARS-CoV-2 assay Rifky Balgahom, Vishal Ahuja, Catherine Pitman, Adam Polkinghorne, James Branley
43 [GO] 2022―Jan―31 Rapid detection of the widely circulating B.1.617.2 (Delta) SARS-CoV-2 variant Adriana E. Rosato, Engy Msiha, Bruce Weng, Michael Mesisca, Ronaldo Gnass, Silvia Gnass, et al. (+3)
44 [GO] 2021―Nov―23 Weak positive SARS-CoV-2 N2 gene results using the Xpress Xpert assay: the need for an alternate interpretative criteria in a low prevalence setting Hemalatha Varadhan, Vishal Ahuja, Catherine Pitman, Dominic E. Dwyer
45 [GO] 2021―Nov―08 Cytotoxic CD8 positive T-lymphocyte infiltration in the lungs as a histological pattern of SARS-CoV-2 pneumonitis Andrii Puzyrenko, Juan C. Felix, Nathan A. Ledeboer, Yunguang Sun, Hallgeir Rui, Yuri Sheinin
46 [GO] 2021―Nov―06 Circulating plasma miR-155 is a potential biomarker for the detection of SARS-CoV-2 infection Riham Abdel-Hamid Haroun, Waleed H. Osman, Rasha E. Amin, Ahmad K. Hassan, Walefed S. Abo-Shanab, Asmaa M. Eessa
47 [GO] 2021―Oct―22 Analytical sensitivity and specificity of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV assay Nicole Isles, Steven G. Badman, Susan Ballard, Bowen Zhang, Benjamin P. Howden, Rebecca Guy, Deborah A. Williamson
48 [GO] 2021―Sep―23 Prolonged PCR positivity in elderly patients infected with SARS-CoV-2 Annaleise R. Howard-Jones, Susan Maddocks, Kerri Basile, Dominic E. Dwyer, James Branley, Jen Kok
49 [GO] 2021―Sep―23 SARS-CoV-2-specific IgM screening has low sensitivity for identifying potentially infectious travellers Tasnim Hasan, Hui Lim, Linda Hueston, Dominic E. Dwyer, Matthew O’Sullivan
50 [GO] 2021―Sep―04 Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting Maryza Graham, Stephen Muhi, Tuyet Hoang, Susan A. Ballard, Julie McAuley, Jason C. Kwong, et al. (+2)
51 [GO] 2021―Aug―10 Use of emerging testing technologies and approaches for SARS-CoV-2: review of literature and global experience for the Australian context Maryza Graham, Susan A. Ballard, Shivani Pasricha, Belinda Lin, Tuyet Hoang, Timothy Stinear, et al. (+5)
52 [GO] 2021―Jul―20 Longitudinal evaluation of laboratory-based serological assays for SARS-CoV-2 antibody detection K.A. Bond, E. Williams, S. Nicholson, S. Lim, D. Johnson, B. Cox, et al. (+10)
53 [GO] 2021―Jun―24 Coronial cases: SARS-CoV-2 infection and Covid-19 Linda Iles
54 [GO] 2021―Jun―24 Coronial cases: SARS-CoV-2 infection and covid-19 Linda Iles
55 [GO] 2021―Jun―24 Coronial cases: SARS-CoV-2 infection and covid-19 Linda Iles
56 [GO] 2021―Jun―24 Clinical forensic medicine and Covid-19 challenges: the melbourne experience Janine Rowse, Nicola Cunningham, Jo Ann Parkin
57 [GO] 2021―Jun―24 Patient blood management - a review of accepted practice; with a focus on optimising patient outcomes during the current COVID-19 pandemic Bryony Ross, Lisa Clarke, Peter Freeman
58 [GO] 2021―Jun―24 COVID-19: 2020 VISION Mike Catton
59 [GO] 2021―Jun―24 Background, testing methods, and laboratory approaches to SARS coronavirus-2 (SARS-CoV-2) and covid19 William D. Rawlinson, Sebastiaan van Hal, Malinna Yeang, Anna Condylios, Zin Naing, Jane-Phan Au, et al. (+2)
60 [GO] 2021―Jun―24 Background, testing methods, and laboratory approaches to SARS coronavirus-2 (SARS-CoV-2) and Covid19 William D. Rawlinson, Sebastiaan van Hal, Malinna Yeang, Anna Condylios, Zin Naing, Jane-Phan Au, et al. (+2)
61 [GO] 2021―Jun―24 Background, testing methods, and laboratory approaches to sars coronavirus-2 (SARS-CoV-2) and covid19 William D. Rawlinson, Sebastiaan van Hal, Malinna Yeang, Anna Condylios, Zin Naing, Jane-Phan Au, et al. (+2)
62 [GO] 2021―Jun―24 Comparative evaluation and longevity of neutralising and binding antibodies for SARS-COV-2 Natalie Davidson, Jenny Evans, Jenny Robson
63 [GO] 2021―Jun―24 Expression of GPI-anchored SARS-CoV-2 receptor binding domain in mammalian cells for serological use M.L. Kernich, P.J. Adamson, J.J. Wang, L.P. Kris, B.L. Armour, D. Beroukas, et al. (+4)
64 [GO] 2021―May―18 SARS-CoV-2 antibodies in the Southern Region of New Zealand, 2020 Alyson Craigie, Reuben McGregor, Alana L. Whitcombe, Lauren Carlton, David Harte, Michelle Sutherland, et al. (+7)
65 [GO] 2021―Mar―20 SARS-CoV-2 viral load dynamics and real-time RT-PCR cycle threshold interpretation in symptomatic non-hospitalised individuals in New Zealand: a multicentre cross sectional observational study Andrew Fox-Lewis, Shivani Fox-Lewis, Jenna Beaumont, Dragana Drinković, Jay Harrower, Kevin Howe, et al. (+10)
66 [GO] 2020―Oct―08 Focus on SARS-CoV-2 and COVID-19 Sharon C-A Chen, William D. Rawlinson
67 [GO] 2020―Oct―08 Laboratory diagnosis of severe acute respiratory syndrome coronavirus 2 T. Gulholm, K. Basile, J. Kok, S.C.-A. Chen, W. Rawlinson
68 [GO] 2020―Oct―08 Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes Gregory Walker, Anupriya Aggarwal, Sonia Underwood, Malinna Yeang, Zin Naing, Alberto Ospina Stella, et al. (+2)
69 [GO] 2020―Oct―05 The impact of viral transport media on PCR assay results for the detection of nucleic acid from SARS-CoV-2 P.D. Kirkland, M.J. Frost
70 [GO] 2020―Sep―30 Accuracy amidst ambiguity: false positive SARS-CoV-2 nucleic acid tests when COVID-19 prevalence is low K. Basile, S. Maddocks, J. Kok, D.E. Dwyer
71 [GO] 2020―Sep―30 Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent Alexa M. Kaufer, Torsten Theis, Katherine A. Lau, Joanna L. Gray, William D. Rawlinson
72 [GO] 2020―Sep―30 Comparative analysis of three laboratory based serological assays for SARS-CoV-2 in an Australian cohort N. Davidson, J. Evans, D. Giammichele, H. Powell, P. Hobson, B. Teis, et al. (+3)
73 [GO] 2020―Sep―30 Head-to-head evaluation on diagnostic accuracies of six SARS-CoV-2 serological assays Shaun S. Tan, Sharon Saw, Ka Lip Chew, Chan Yiong Huak, Candy Khoo, Anastacia Pajarillaga, et al. (+5)
74 [GO] 2020―Sep―29 Is prostate infarction and acute urinary retention a possible complication of severe COVID-19 infection? Sergio A.C. Duarte, Jessica G. Pereira, Alexandre Iscaife, Katia R.M. Leite, Alberto A. Antunes
75 [GO] 2020―Sep―22 Sample pooling is a viable strategy for SARS-CoV-2 detection in low-prevalence settings Brian S.W. Chong, Thomas Tran, Julian Druce, Susan A. Ballard, Julie A. Simpson, Mike Catton
76 [GO] 2020―Sep―22 Clinical evaluation of SARS-CoV-2 point-of-care tests Roselle s. Robosa, Indy Sandaradura, Dominic e. Dwyer, Matthew v.N. O’sullivan
77 [GO] 2020―Sep―21 Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection Kyra Y.L. Chua, Sara Vogrin, Intissar Bittar, Jennifer H. Horvath, Hari Wimaleswaran, Jason A. Trubiano, et al. (+2)
78 [GO] 2020―Sep―01 Implementation and evaluation of a novel real-time multiplex assay for SARS-CoV-2: in-field learnings from a clinical microbiology laboratory Eloise Williams, Katherine Bond, Brian Chong, Dawn Giltrap, Malcolm Eaton, Peter Kyriakou, et al. (+7)
79 [GO] 2020―Aug―19 SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings Phoebe C.M. Williams, Annaleise R. Howard-Jones, Peter Hsu, Pamela Palasanthiran, Paul E. Gray, Brendan J. McMullan, et al. (+2)
80 [GO] 2020―Aug―19 Contamination of SARS-CoV-2 RT-PCR probes at the oligonucleotide manufacturer Claire Y.T. Wang, Cameron Buckley, Cheryl Bletchly, Patrick Harris, David Whiley
81 [GO] 2020―Aug―12 Histopathology of cutaneous COVID-19 lesion: possible SARS-CoV-2 cytopathogenic effect Kinan Drak Alsibai, Celine Michaud, Alex Taquet, Magalie Demar, Romain Blaizot
82 [GO] 2020―Jul―10 Rapid deployment of pathology services to a remote Australian quarantine setting during the COVID-19 pandemic James Branley, Matthew O’Sullivan, Adam Polkinghorne, Marin Poljak, Dianne Stephens
 [1] 

82 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec